MannKind Quarterly Cash Flow Statement
NASDAQ: MNKDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MannKind free cash flow
In the quarter ended Jun 30, 2026, MannKind generated -$18.4 million of operating cash flow and spent $5.1 million on capital expenditures. That left free cash flow of -$23.5 million, a free-cash-flow margin of -21.4% of revenue. Free cash flow was down 399.4% from the prior year's $7.8 million.
Summary generated from market data by MetaCap's automated system. Methodology
MannKind cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -19.03M | -16.62M | -15.95M | 7.99M | 668.00K | 13.16M | 7.42M | 11.55M | -2.01M | 10.63M | 1.40M | 1.72M |
| Net Income growth (YoY) | -2949.10% | -226.30% | -314.87% | -30.87% | — | +23.78% | +429.76% | +571.12% | — | — | — | — |
| Depreciation & Amortization | 6.40M | 6.38M | 6.03M | 2.06M | 2.09M | 2.11M | 2.16M | 2.12M | 1.73M | 1.36M | 1.23M | 1.03M |
| Stock-Based Compensation | 10.23M | 6.46M | 6.97M | 4.32M | 7.52M | 5.38M | 5.82M | 5.23M | 6.43M | 3.88M | 3.81M | 4.60M |
| Change in Working Capital | -14.85M | -4.82M | -18.97M | 6.90M | 228.00K | -26.43M | -5.29M | -2.63M | -3.63M | -10.66M | 3.89M | 12.85M |
| Operating Cash Flow | -18.37M | -5.37M | -7.96M | 23.64M | 8.95M | -6.38M | 22.64M | 9.33M | 3.83M | 6.70M | 21.68M | 8.66M |
| Capital Expenditures | -5.08M | -1.88M | -1.99M | -1.13M | -1.12M | -330.00K | -2.90M | -1.42M | -2.97M | -2.41M | -5.87M | -11.39M |
| Investing Cash Flow | 17.91M | 18.73M | -291.96M | -25.06M | 6.26M | 5.96M | 48.22M | -41.26M | -55.18M | -48.44M | -7.89M | -11.55M |
| Debt Issued | — | — | 250.00M | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | 559.00K | -35.41M | 247.41M | 71.81M | -5.51M | 1.39M | -86.90M | -2.34M | -44.55M | -3.47M | 141.68M | -283.00K |
| Net Change in Cash | 97.00K | -22.05M | -52.51M | 70.39M | 9.70M | 975.00K | -16.03M | -34.27M | -95.90M | -45.21M | 155.46M | -3.17M |
| Free Cash Flow | -23.45M | -7.25M | -9.95M | 22.52M | 7.83M | -6.71M | 19.75M | 7.91M | 861.00K | 4.29M | 15.80M | -2.72M |
This table shows 12 quarterly periods of MannKind's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MNKD's reporting calendar. What is a cash flow statement?